PET/CT with 68Ga-DOTA-TATE and 68Ga-FAPI in the Diagnosis of Neuroendocrine Tumors. Clinical Cases-Reference-Cited by-同舟云学术

PET/CT with 68Ga-DOTA-TATE and 68Ga-FAPI in the Diagnosis of Neuroendocrine Tumors. Clinical Cases

Published:2024-07-04 Issue:2 Volume:7 Page:9-14
ISSN:2713-167X
Container-title:Journal of oncology: diagnostic radiology and radiotherapy
language:
Short-container-title:jour

Author:

Belkin E. V.¹,Tulin P. E.¹^ORCID,Odzharova A. A.¹^ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology

Abstract

Purpose: To perform a comparative analysis of diagnostic efficiency of PET/CT with 68Ga-DOTA-TATE and 68Ga-FAPI on the example of clinical cases of NEO (detection of primary tumor and extra-organ metastases).Material and methods: Two patients with pancreatic NEO underwent PET/CT studies with 68Ga-DOTA-TATE and 68Ga-FAPI before treatment. PET/CT with 68Ga-DOTA-TATE successfully visualized primary tumors in both patients; evidence of a metastatic process in the liver was obtained in one patient. PET/CT with 68Ga-FAPI showed non-optimal visualization of primary tumors, no liver metastases were detected.Conclusion: PET/CT with 68Ga-DOTA-TATE is a more effective method of radionuclide diagnostics of NEO than PET/CT with 68Ga-FAPI.

Publisher

Non-profit partnership Society of Interventional Oncoradiologists

Reference21 articles.

1. Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004 Aug; 1:3-7. https://doi.org/10.1159/000080731.

2. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008 Jan; 9(1):61- 72. https://doi.org/10.1016/s1470-2045(07)70410-2.

3. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci. 2004 Apr; 1014:13-27. https://doi.org/10.1196/annals.1294.002.

4. Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008 Jun; 26(18):3063-72. https://doi.org/10.1200/JCO.2007.15.4377.

5. Kulke MH. Somatostatin analogues in neuroendocrine tumors. J Natl Compr Canc Netw. 2016 Mar; 14(3):241-42. https://doi.org/10.6004/jnccn.2016.0029.